中国医药
中國醫藥
중국의약
CHINA MEDICINE
2009年
6期
450-451
,共2页
慢性乙型肝炎%阿德福韦酯%甘草酸二铵
慢性乙型肝炎%阿德福韋酯%甘草痠二銨
만성을형간염%아덕복위지%감초산이안
Chronic hepatitis B%Adefovir dipivoxil%Diammonium glycyrrhizinate
目的 观察阿德福韦酯联合甘草酸二铵治疗HBeAg阳性慢性乙型肝炎的临床疗效.方法 85例HBeAg阳性慢性乙型肝炎患者中结合患者的治疗意愿选择46例作为治疗组,应用阿德福韦酯胶囊联合注射用甘草酸二铵治疗;39例为对照组,单用阿德福韦酯胶囊治疗.观察治疗12周末和24周末2组患者肝病症状、丙氨酸转氨酶(ALT)和HBVDNA的变化.结果 12周末时治疗组患者乏力、食欲不振和肝区不适等症状明显缓解,ALT明显下降,与对照组相比,差异有统计学意义(P<0.01).24周末时治疗组ALT较对照组仍持续稳定(P<0.01),2组乏力、食欲不振和肝区不适等症状都明显缓解.治疗12周末和24周末时2组患者HBVDNA在血中的水平都明显下降,差异无统计学意义(P>0.05).结论 联合应用阿德福韦酯胶囊和注射用甘草酸二铵治疗HBeAg阳性慢性乙型肝炎患者,与单用阿德福韦酯胶囊治疗的HBeAg阳性慢性乙型肝炎患者相比较,能够在抗HBV治疗的同时较快控制肝组织炎症、坏死,改善患者的临床症状,降低血清ALT,增强了患者治疗疾病的信心和治疗的依从性,可达到长期改善肝功能、稳定肝炎病情的目的 .
目的 觀察阿德福韋酯聯閤甘草痠二銨治療HBeAg暘性慢性乙型肝炎的臨床療效.方法 85例HBeAg暘性慢性乙型肝炎患者中結閤患者的治療意願選擇46例作為治療組,應用阿德福韋酯膠囊聯閤註射用甘草痠二銨治療;39例為對照組,單用阿德福韋酯膠囊治療.觀察治療12週末和24週末2組患者肝病癥狀、丙氨痠轉氨酶(ALT)和HBVDNA的變化.結果 12週末時治療組患者乏力、食欲不振和肝區不適等癥狀明顯緩解,ALT明顯下降,與對照組相比,差異有統計學意義(P<0.01).24週末時治療組ALT較對照組仍持續穩定(P<0.01),2組乏力、食欲不振和肝區不適等癥狀都明顯緩解.治療12週末和24週末時2組患者HBVDNA在血中的水平都明顯下降,差異無統計學意義(P>0.05).結論 聯閤應用阿德福韋酯膠囊和註射用甘草痠二銨治療HBeAg暘性慢性乙型肝炎患者,與單用阿德福韋酯膠囊治療的HBeAg暘性慢性乙型肝炎患者相比較,能夠在抗HBV治療的同時較快控製肝組織炎癥、壞死,改善患者的臨床癥狀,降低血清ALT,增彊瞭患者治療疾病的信心和治療的依從性,可達到長期改善肝功能、穩定肝炎病情的目的 .
목적 관찰아덕복위지연합감초산이안치료HBeAg양성만성을형간염적림상료효.방법 85례HBeAg양성만성을형간염환자중결합환자적치료의원선택46례작위치료조,응용아덕복위지효낭연합주사용감초산이안치료;39례위대조조,단용아덕복위지효낭치료.관찰치료12주말화24주말2조환자간병증상、병안산전안매(ALT)화HBVDNA적변화.결과 12주말시치료조환자핍력、식욕불진화간구불괄등증상명현완해,ALT명현하강,여대조조상비,차이유통계학의의(P<0.01).24주말시치료조ALT교대조조잉지속은정(P<0.01),2조핍력、식욕불진화간구불괄등증상도명현완해.치료12주말화24주말시2조환자HBVDNA재혈중적수평도명현하강,차이무통계학의의(P>0.05).결론 연합응용아덕복위지효낭화주사용감초산이안치료HBeAg양성만성을형간염환자,여단용아덕복위지효낭치료적HBeAg양성만성을형간염환자상비교,능구재항HBV치료적동시교쾌공제간조직염증、배사,개선환자적림상증상,강저혈청ALT,증강료환자치료질병적신심화치료적의종성,가체도장기개선간공능、은정간염병정적목적 .
Objective To evaluate the efficacy of combined Adefovir dipivoxil and Diammonium Glycyrrhizinate for treatment of HbeAg-positive chronic hepatitis B. Methods Fourty-six cases with HbeAg-positive chronic hepatitis B who were heated with Adofovir dipivoxil and Diammonium Glycyrrhizinate (Treatment group) were enrolled, together with 39 cases with HbeAg-positive chronic hepatitis B who were treated with Adefovir dipivoxil alone(Control group). Symptoms, ALT level and HBV-DNA were observed at the end of 12 th and 24 th week. Results The remission of symptom of Hypodynamia, Anorexia, Hepatic region compl, and the decrease of the level of ALT on treatment group were more significant than those of control group at the end of 12 th week( P < 0.01). The decrease of ALT level was more significant (P <0.01)than that of control group at the end of 24 th week. But the remission of symptom of Hypodynamia, Anorexia, Hepatic region were not significant between the 2 groups (P>0.05). The level of HBV-DNA of beth groups significantly decreased at the end of 12 th and 24 th week. But the decrease of the level of HBV-DNA in treatment group were less significant than that on control group (P > 0.05 ). Condusion The efficacy of combined Adefovir dipivoxil and Diammonium glycyrrthzinate is higher than that of Adefovir dipivoxil alone.